Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have been given an average rating of “Reduce” by the sixteen brokerages that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $10.5667.
AVTR has been the topic of a number of recent analyst reports. Wells Fargo & Company lowered their price target on shares of Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Royal Bank Of Canada initiated coverage on shares of Avantor in a report on Thursday, May 14th. They set a “sector perform” rating and a $9.00 price target on the stock. Wolfe Research downgraded shares of Avantor to an “underperform” rating and set a $7.00 price target on the stock. in a report on Monday, June 1st. UBS Group restated a “neutral” rating and set a $10.50 price objective on shares of Avantor in a research report on Thursday, February 12th. Finally, TD Cowen restated a “hold” rating on shares of Avantor in a research report on Thursday, February 12th.
View Our Latest Stock Analysis on AVTR
Insider Transactions at Avantor
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Private Trust Co. NA grew its holdings in shares of Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Avantor by 28.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock worth $49,000 after acquiring an additional 905 shares during the last quarter. Osaic Holdings Inc. lifted its position in shares of Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Avantor by 17.6% during the 4th quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock worth $84,000 after buying an additional 1,101 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Avantor by 119.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.
Avantor Stock Up 5.8%
AVTR stock opened at $9.70 on Thursday. The firm’s fifty day simple moving average is $8.22 and its 200-day simple moving average is $9.66. The company has a market capitalization of $6.62 billion, a P/E ratio of -11.97, a price-to-earnings-growth ratio of 5.31 and a beta of 0.97. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. Avantor has a 12 month low of $7.26 and a 12 month high of $15.93.
Avantor (NYSE:AVTR – Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The business’s revenue for the quarter was up .0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.23 EPS. As a group, equities research analysts forecast that Avantor will post 0.79 earnings per share for the current year.
Avantor Company Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Read More
- Five stocks we like better than Avantor
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
